7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one has been researched along with Ectopic Ossification in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, L; Gerard, NP; Kan, L; Kaplan, FS; Kessler, JA; Liu, Y; Lounev, VY; Lu, B; McGuire, TL; Pignolo, RJ; Shore, EM; Stock, SR | 1 |
1 other study(ies) available for 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one and Ectopic Ossification
Article | Year |
---|---|
Substance P signaling mediates BMP-dependent heterotopic ossification.
Topics: Animals; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Female; Humans; Immunohistochemistry; Isoindoles; Male; Mice; Mice, Transgenic; Myositis Ossificans; Neurokinin-1 Receptor Antagonists; Ossification, Heterotopic; Protein Precursors; Receptors, Neurokinin-1; Sensory Receptor Cells; Substance P; Tachykinins | 2011 |